Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Michael Case, MS
JCP
Original Research
Assessment of Treatment Algorithms Including Amantadine, Metformin, and Zonisamide for the Prevention of Weight Gain With Olanzapine: A Randomized Controlled Open-Label Study
May 17, 2011
Vicki Poole Hoffmann
,
Michael Case
,
Jennie G. Jacobson
JCP
Original Research
Olanzapine/Fluoxetine Combination in Patients With Treatment-Resistant Depression: Rapid Onset of Therapeutic Response and Its Predictive Value for Subsequent Overall Response in a Pooled Analysis of 5 Studies
February 23, 2010
Mauricio Tohen
,
Michael Case
,
Madhukar H. Trivedi
, et al
JCP
Original Research
An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression
March 10, 2009
Madhukar H. Trivedi
,
Michael E. Thase
,
Olawale Osuntokun
, et al
JCP
Original Research
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder
February 15, 2007
Michael E. Thase
,
Sara A. Corya
,
Olawale Osuntokun
, et al
JCP
Original Research
Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance
October 14, 2005
Richard C. Shelton
,
Douglas J. Williamson
,
Sara A. Corya
, et al
JCP
Original Research
Analyses of Treatment-Emergent Mania With Olanzapine/Fluoxetine Combination in the Treatment of Bipolar Depression
May 15, 2005
Sara A. Corya
,
Lori L. Altshuler
,
Terence A. Ketter
, et al
